Skip directly to Accessibility Notice
VanEck logo

BBH
VanEck Vectors Biotech ETF

Latest Market Updates*

  • The biotech sector is attracting a wave of investor interest as companies race to meet soaring global demand for COVID-19 diagnostics and treatment.
  • Demand is expected to outstrip supply for the foreseeable future.
  • Optimism about recent developments by some biotech firms has also helped lift the sector’s performance so far this year.
  • Gilead Sciences and Moderna are two of BBH’s top 10 holdings. Gilead recently indicated that the trial for coronavirus treatment Remdesivir has met its initial goal, and the U.S. Food and Drug Administration (FDA) is fast tracking Moderna’s experimental COVID-19 vaccine through the regulatory review process.

Learn more: Race for the Cure Drives Biotech Stocks

Fund Description

VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

 
 

  • Fund Ticker

    BBH
  • Exchange

    NASDAQ
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVBBHTR
  • Index Rebalancing

    Quarterly

 
as of 09/23/20

  • 30-Day SEC Yield1

    0.44%
  • Total Net Assets

    $467.3M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.40%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Annual

Index Key Points

Underlying Index: MVIS US Listed Biotech 25 Index (MVBBHTR) 

The Index comprises:

U.S. exchange-listed companies that derive most of their revenues from bio-technology, including companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment

Companies initially eligible for inclusion in Index:

  • Principally engaged in the bio-technology industry, deriving greater than 50% of revenues from it
  • Full market capitalization exceeding $150 million
  • Three-month average-daily-trading volume of at least $1 million
  • At least 250,000 shares traded per month

Index provider:

MV Index Solutions 

Index Profile

  • Ticker

    MVBBHTR
  • Inception Date

    08/12/2011
  • Rebalance Frequency

    Quarterly

Index Top 10 Constituents (%) as of 08/31/20 Download All Index Constituents

Total Constituents: 24
Swipe
to view
full data
Constituent Name
Ticker
Weightings (%)
Amgen Inc
AMGN US
16.05
Gilead Sciences Inc
GILD US
8.48
Vertex Pharmaceuticals Inc
VRTX US
5.68
Iqvia Holdings Inc
IQV US
5.51
Moderna Inc
MRNA US
5.09
Regeneron Pharmaceuticals
REGN US
5.00
Illumina Inc
ILMN US
4.96
Biogen Idec Inc
BIIB US
4.80
Incyte Corp
INCY US
4.57
Alexion Pharmaceuticals Inc
ALXN US
4.17
Top 10 Total (%) 64.31
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Index Country Weightings (%) as of 08/31/20

  • Country

    Weightings (%)
  • United States

    96.0
  • China

    2.5
  • Spain

    1.5

Index Sector Weightings (%) as of 08/31/20

  • Sector

    Weightings (%)
  • Health Care

    100.0